Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjunctive Curcumin for Depression
NCT01750359Phase 4Completed
- Start
- Aug 2010
- Primary completion
- May 2011
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of curcumin in major depressive disorder (MDD). Started Aug 2010; status: completed.
02
Drugs
curcumin
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT01750359.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01750359.